Late intensification is superior to early intensification in relapsing/refractory aggressive non-Hodgkin's lymphoma. A randomized study from the GELA: LNH RP93.
Bosly, A., Sonet, A., Salles, G., Brice, P., Haioun, C., Kerneis, Y., Tilly, H., Lederlin, P., Plantier, I., Sebban, C., & Coiffier, B. (1997). Late intensification is superior to early intensification in relapsing/refractory aggressive non-Hodgkin’s lymphoma. A randomized study from the GELA: LNH RP93. Experimental Hematology, 25(8), 16. (Original work published 1997)